The Ledger

A health system affiliate raised its bid for Surgery Partners to $25 a share in cash, up to about $6.0 billion including debt, after an unnamed bidder offered $28. UPDATE on our October 26 coverage. HealthSpan Partners, a contractual affiliate of Bon Secours Mercy Health, amended its merger agreement on the surgery center operator, and the companies’ joint press release, dated November 9, says the new price replaces $23.50 in the original October agreement. If the deal has stockholder approval but has not closed by March 1, 2027, holders other than Bain Capital affiliates earn a ticking fee of 10% a year on the $25, paid monthly, worth up to $1.61 a share and capping consideration at $26.61 if closing runs to the October 23, 2027 outside date. The release says a third party made a nonbinding $28 cash proposal on November 3 and updated it November 8. The special committee of independent directors ruled it not a “Superior Proposal,” citing a longer or uncertain path to close, greater regulatory risk and weaker contractual protections. Bain, with about 39% of the stock, keeps its voting agreement and rolls its shares into the buyer. Who it hits: surgery center and physician-partnership operators, rival bidders for ambulatory assets, and the hospital systems whose outpatient referrals run through Surgery Partners’ more than 200 locations. So what: a higher-priced rival lost on regulatory certainty, which tells corporate development teams that a nonprofit-affiliated buyer is being treated as the safer path to close. Close is still expected in the first quarter of 2027, subject to a stockholder vote and regulatory approvals. Confidence: High on the terms, which come from the filing; Med on completion, since the rival bidder has not been named and could return.

Parkview Health said Monday it has completed its purchase of Ovation Healthcare, the shared-services firm that serves more than 500 healthcare organizations in 48 states. WPTA 21Alive reports that Ovation, based in Tennessee, will keep operating as a separate organization with its own governing board, and that Parkview, the 16-hospital Indiana system, expects lower administrative costs and better affordability for community hospitals. No price was disclosed. On October 16, per Becker’s Hospital Review, Moody’s Investors Service moved Parkview’s outlook to negative from stable, citing higher leverage from a planned $550 million bond issue and execution risk across several growth initiatives. Who it hits: community hospitals that buy revenue cycle and purchasing services, and any system weighing a vendor-ownership model. So what: a health system now owns a vendor that sells to its competitors, which is a conflict-of-interest question buyers should ask about. Confidence: Med. The close comes from local reporting and no Parkview release was located, and the Moody’s detail is a secondary summary.

Rockwell Medical agreed on November 3 to buy most of Vantive’s hemodialysis business for $125 million, plus up to $45 million tied to revenue and EBITDA milestones. The Rockwell Form 8-K press release says the purchase covers dialysis concentrates, machines including the AK-98, water treatment systems, consumables and technical services, plus a roughly one-million-square-foot manufacturing campus in Medolla, Italy. Vantive itself finances the base price through two $50 million term loans and a $25 million convertible note. Rockwell, a U.S. dialysis concentrate maker, withdrew its 2026 guidance because of deal costs and projects combined annual revenue of $400 million to $450 million. Closing is expected in mid-2027, pending regulatory approvals. Who it hits: dialysis clinics and operators that buy machines and concentrate. So what: the seller is financing the buyer, so Vantive stays economically tied to the business through the transition. The release gives no standalone revenue for the acquired unit, so the combined figure is an estimate. This deal is older than our 48-hour window; we had not covered it. Confidence: High on terms, Low on the revenue projection.

A note on today’s scan: Monday was light for earnings and rating actions. Redeemer Health’s bid procedures deadline of about November 15 has no new public filing yet, and no new terms appeared on the pending Option Care Health or Definitive Healthcare proposals.

THE DEAL SHEET

Target	Acquirer/Investor	Vertical	Value	Source
Surgery Partners (amended agreement)	HealthSpan Partners (Bon Secours Mercy Health affiliate); Bain Capital rolls its stake	Ambulatory surgery centers and surgical hospitals	$25.00 per share cash, up to about $6.0 billion enterprise value, ticking fee up to $1.61 per share	Surgery Partners press release
Ovation Healthcare (reported closed)	Parkview Health	Hospital shared services and revenue cycle	Not disclosed	WPTA 21Alive
Vantive hemodialysis business (announced November 3)	Rockwell Medical	Dialysis equipment and supplies	$125 million plus up to $45 million contingent	Rockwell Form 8-K press release